Priceman team 💪🏻 @SaulPriceman https://t.co/oWoUrcEayS
6 followers
495 followers
🔬 Data published by @cityofhope from a Phase 1 CAR-T therapy trial in prostate cancer shows promising results. As momentum of CAR-T cell therapy approvals increases, finding ways to scale therapeutic manufacturing is critical. Read more in @Nature ⬇️
358 followers
PROSTATE: in a first in human study, prostate stem cell antigen (PSCA) directed CAR T therapy showed modest activity (fall in PSA in 30%) and good tolerability; CAR T cell persistence beyond 28 days was limited. https://t.co/fbatNGuBvQ
32,082 followers
RT @NatureMedicine: A phase 1 trial of PSCA-targeting #CARTcell therapy in patients with #PSCA positive #prostate cancer demonstrates the t…